/Health District to Notify Patients

Health District to Notify Patients

March 15, 2011

LAS VEGAS – The Southern Nevada Health District is coordinating with the Nevada State Board of Medical Examiners to identify patients who underwent prostate biopsies conducted by Dr. Michael Kaplan during the period from December 20, 2010 through March 11, 2011. A joint investigation conducted by the Board of Medical Examiners and the Food and Drug Administration Office of Criminal Investigation found Dr. Kaplan reused endocavity needle guides, which are single-use-only medical devices, while performing some of these biopsies.

At this time, no known cases of disease transmission have been identified as a result of this infection control breach. However, based on the current information, and in consultation with the Centers for Disease Control and Prevention, it has been determined that a patient notification is warranted. The health district will conduct a formal notification once the process of identifying patients who underwent the procedure is completed and recommendations based on the ongoing investigation are finalized. In the interim, patients of Dr. Kaplan who underwent a prostate biopsy during the identified period of time are encouraged to speak with their personal physician about any concerns they may have.

Updated information about the Southern Nevada Health District can be found on Facebook www.facebook.com/SouthernNevadaHealthDistrict, on YouTube www.youtube.com/SNHealthDistrict or Twitter www.twitter.com/SNHDinfo.

Visit the Media Contacts webpage for media related inquiries.


The Southern Nevada Health District serves as the local public health authority for Clark County, Boulder City, Henderson, Las Vegas, Mesquite and North Las Vegas. The agency safeguards the public health of the community’s residents and visitors through innovative programs, regulations, and initiatives focused on protecting and promoting their health and well-being. More information about the Health District, its programs, services, and the regulatory oversight it provides is available at www.SNHD.info.